Education
About Us
Working with TipRanks
Follow Us
Parkway Corporate Limited (DE:4IP)
FRANKFURT:4IP
4IP Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthConsistent mid-single-digit revenue growth indicates sustained patient demand and utilization across facilities. That revenue base supports operational stability, helps absorb fixed costs, and provides a durable platform for gradual margin improvement and reinvestment over the next 2–6 months.
Moderate Leverage And Solid Equity RatioA moderate debt burden with a 60% equity ratio implies a stable capital structure and manageable refinancing needs. This financial flexibility reduces solvency risk, enabling continued investment in facilities and working capital without immediate pressure from high leverage.
Integrated Hospital And Diagnostic NetworkA combined hospital and diagnostic footprint creates recurring, diversified revenue streams (inpatient, outpatient, diagnostics). This structural positioning in essential health services supports steady patient flows, barriers to entry, and operational cross-selling that remain relevant over months.
Bears Say
Very Weak ProfitabilityVery low gross and net margins limit the company's ability to retain earnings and buffer cost shocks. Persistently thin profitability undermines capacity to fund capex from operations, restricts margin improvement levers, and weakens long-term earnings resilience despite revenue growth.
Sharp Decline In Free Cash FlowA large FCF decline signals weaker cash conversion and potential liquidity constraints. Reduced free cash curtails maintenance and expansion of clinical capacity, increases reliance on external financing, and elevates execution risk for strategic initiatives over coming quarters.
Extremely Low Return On EquityROE near zero implies the company is not generating meaningful returns on shareholder capital. This points to operational inefficiencies or underutilized assets, making it harder to justify new equity investment and to create shareholder value absent clear improvement plans.
Parkway Corporate Limited News
4IP FAQ
What was Parkway Corporate Limited’s price range in the past 12 months?
Currently, no data Available
What is Parkway Corporate Limited’s market cap?
Parkway Corporate Limited’s market cap is €15.09M.
When is Parkway Corporate Limited’s upcoming earnings report date?
Parkway Corporate Limited’s upcoming earnings report date is Sep 24, 2026 which is in 184 days.
How were Parkway Corporate Limited’s earnings last quarter?
Parkway Corporate Limited released its earnings results on Feb 27, 2026. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Parkway Corporate Limited overvalued?
According to Wall Street analysts Parkway Corporate Limited’s price is currently Undervalued.
Does Parkway Corporate Limited pay dividends?
Parkway Corporate Limited does not currently pay dividends.
What is Parkway Corporate Limited’s EPS estimate?
Parkway Corporate Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parkway Corporate Limited have?
Parkway Corporate Limited has 2,768,910,600 shares outstanding.
What happened to Parkway Corporate Limited’s price movement after its last earnings report?
Parkway Corporate Limited reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Parkway Corporate Limited?
Currently, no hedge funds are holding shares in DE:4IP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Parkway Corporate Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-1.49%
Trailing 12-Months
Asset Growth
-2.26%
Trailing 12-Months
Company Description
Parkway Corporate Limited
Parkway Corporate Limited, a cleantech company, provides water treatment solutions in Australia. It operates through three business units: Parkway Process Solutions, Parkway Process Technologies, and Parkway Ventures. The company offers analytical instruments for measuring water treatment related parameters; laboratory equipment; laboratory consumables, such as syringes, test tubes, measuring jugs, cylinders, and flasks; water treatment systems; and a range of pumps comprising specialty chemical dosing pumps, HVAC pumps, submersible pumps, and high-pressure and high-capacity pumps, as well as related parts and accessories. It also provides instrumentation and controllers to measure, monitor, and automate water treatment operations; pipe, hose, and fittings products; valves and solenoids; filters, membranes, and related process equipment; and a range of tanks for high-value industrial water treatment and process related applications. In addition, the company offers various water treatment chemicals; and disinfection products that consist of chemical disinfection, chlorination equipment, ozone disinfection, and UV disinfection products, as well as related parts and accessories. Further, it provides analytical testing, project evaluation, process development, project engineering, installation and project management, and operation and maintenance services. Additionally, the company holds interest in the Karinga Lakes potash project located in the northern territory of Australia; and owns a portfolio of industrial wastewater treatment technologies. The company was formerly known as Parkway Minerals NL and changed its name to Parkway Corporate Limited in September 2021. The company was incorporated in 2010 and is based in Sunshine North, Australia.
Agrimin Limited
―
American West Metals Ltd.
―
WA Kaolin Ltd.
―
Arizona Lithium Limited
―
Richmond Vanadium Technology Pty Ltd.
―